HIGHLIGHTS
- who: . and collaborators from the Catholic University of the Sacred Heart, Italy have published the research work: Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease, in the Journal: (JOURNAL) of 31/Dec/2017
- what: This study demonstrated that metformin use in patients with T2DM and COPD was associated with significantly lower risks of composite cardiovascular events, CAD, stroke, and heart failure.
- how: The authors conducted this retrospective cohort study to investigate whether the influence of metformin use on CVD in patients with comorbid T2DM and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.